Vice President, Access, Value Evidence & Pricing

Role: Vice President, Access, Value Evidence & Pricing at Rocket Pharma, leading global value, pricing, reimbursement, and patient access strategies for gene therapies. Responsibilities: develop and execute integrated market access plans across U.S. and international markets, including payer strategy, HEOR, evidence generation, and policy shaping; oversee treatment center enablement, patient services, and channel strategy; build and lead a high-performing team; and engage with external stakeholders such as payers, policy authorities, and advocacy groups. Requirements: Bachelor’s degree with advanced degree (MBA, PharmD, PhD, MD, MPH) preferred; 15+ years of progressive commercial leadership in biopharma, with expertise in gene therapy, market access, pricing, HEOR, and innovative reimbursement models; deep knowledge of U.S. Buy & Bill, specialty pharmacy, and complex therapy access dynamics. HighValue: gene therapies, rare diseases, market access, pricing, reimbursement, HEOR, U.S. and international markets, innovative contracting; international travel (~40%). WorkSetup: not specified but implies leadership across global markets with domestic and international engagement.